Ryan Allway May 7th, 2024 News, Top News, Top Story FT. LAUDERDALE, FL / ACCESSWIRE / May 7, 2024 / Kaya Holdings, Inc., (“KAYS” or the “Company”) (OTCQB:KAYS) announced today that the Company has been awarded its license to operate a Psilocybin Service Center by the Oregon Health Authority (the... Read more
Ryan Allway December 30th, 2021 U.S. FDA granted JZP150 Fast Track designation in PTSD, underscoring the unmet needs of patients If approved, JZP150 would become the first new drug approved in 20 years for patients with PTSD; topline data readout anticipated by the end of 2023 DUBLIN, Dec. 30, 2021 /PRNewswire/... Read more
Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms
May 25, 2021
Ryan Allway May 25th, 2021 Psychedelics DENVER, May 25, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced today... Read more
Lobe Sciences Announces Filing of PCT Application
April 29, 2021
Ryan Allway April 29th, 2021 Psychedelics Vancouver, British Columbia–(Newsfile Corp. – April 29, 2021) – Lobe Sciences Ltd. (“Lobe“) (CSE: LOBE) (OTC Pink: GTSIF) is pleased to announce the filing of a key Patent Cooperation Treaty (“PCT”) application entitled Methods, Compositions and Devices for Treating Mild Traumatic Brain Injury,... Read more
